You Are Leaving Avistone's Website
You have selected a link that will take you to a site maintained by a third party. Avistone provides this link as a service to website visitors. Avistone is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Click 'Cancel' to return to Avistone's site or 'Continue' to proceed.
ACADEMIC ARTICLE
-
Latest Data of Vebreltinib on MET Amplification from the KUNPENG Study Published in The Lancet Oncology
Author:Yilong Wu, Yu Yao et al.
Time:2025-12-06
2025
12-06
View Details
-
Vebreltinib's Pivotal Registration Study Results in JCO
Author:Yi-Long Wu, Jin-Ji Yang et al.
Time:2024-07-26
2024
07-26
View Details
-
Mechanism of Vebreltinib in Glioma and Phase I Trial Results in Cell
Author:Tao Jiang, Humin Hu et al.
Time:2018-11-29
2018
11-29
View Details